Low-grade dysplasia in Barrett's esophagus: A problematic diagnosis

Weusten, 2017, Endoscopic management of Barrett's esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement, Endoscopy, 49, 191, 10.1055/s-0042-122140 Fitzgerald, 2014, British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus, Gut, 63, 7, 10.1136/gutjnl-2013-305372 Sharma, 2020, AGA clinical practice update on endoscopic treatment of Barrett's esophagus with dysplasia and/or early cancer: expert review, Gastroenterology, 158, 760, 10.1053/j.gastro.2019.09.051 Spechler, 2011, American Gastroenterological Association medical position statement on the management of Barrett's esophagus, Gastroenterology, 140, 1084, 10.1053/j.gastro.2011.01.031 Whiteman, 2015, Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma, J Gastroenterol Hepatol, 30, 804, 10.1111/jgh.12913 Japan Esophageal Society. Japanese classification of esophageal cancer, 11th Edition: Part I. Esophagus 2017; 14: 1–36. Falk, 2002, Barrett's esophagus, Gastroenterology, 122, 1569, 10.1053/gast.2002.33427 Bennett, 2015, BOB CAT: a large-scale review and delphi consensus for management of barrett's esophagus with no dysplasia, indefinite for, or low-grade dysplasia, Am J Gastroenterol, 110, 662, 10.1038/ajg.2015.55 Riddell, 2009, Definition of Barrett's esophagus: time for a rethink – is intestinal metaplasia dead?, Am J Gastroenterol, 104, 2588, 10.1038/ajg.2009.390 Lavery, 2016, Evolution of oesophageal adenocarcinoma from metaplastic columnar epithelium without goblet cells in Barrett's oesophagus, Gut, 65, 907, 10.1136/gutjnl-2015-310748 Takubo k, 2009, Cardiac rather than intestinal-type background in endoscopic resection specimens of minute Barrett adenocarcinoma, Hum Pathol, 40, 65, 10.1016/j.humpath.2008.06.008 Falk, 2017, Current management of low-grade dysplasia in Barrett esophagus, Gastroenterol Hepatol (N Y), 13, 221 Peters, 2019, Incidence of progression of persistent nondysplastic Barrett's esophagus to malignancy, Clin Gastroenterol Hepatol, 17, 869, 10.1016/j.cgh.2018.08.033 Goldblum, 2010, Controversies in the diagnosis of Barrett esophagus and Barrett-related dysplasia: one pathologist's perspective, Arch Pathol Lab Med, 134, 1479, 10.5858/2010-0249-RA.1 Di Pietro, 2019, Development and validation of confocal endomicroscopy diagnostic criteria for low-grade dysplasia in Barrett's esophagus, Clin Transl Gastroenterol, 10, e00014, 10.14309/ctg.0000000000000014 Cameron, 1997, Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study, Am J Gastroenterol, 92, 586 Weusten, 2017, Endoscopic management of Barrett's esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement, Endoscopy, 49, 191, 10.1055/s-0042-122140 Shaheen, 2016, ACG clinical guideline: diagnosis and management of Barrett's esophagus, Am J Gastroenterol, 111, 30, 10.1038/ajg.2015.322 Kestens, 2016, Patients with Barrett's esophagus and persistent low-grade dysplasia have an increased risk for high-grade dysplasia and cancer, Clin Gastroenterol Hepatol, 14, 956, 10.1016/j.cgh.2015.12.027 Phoa, 2014, Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial, JAMA, 311, 1209, 10.1001/jama.2014.2511 El-Serag, 2014, Update on the epidemiology of gastro-esophageal reflux disease: a systematic review, Gut, 63, 871, 10.1136/gutjnl-2012-304269 Desai, 2012, The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis, Gut, 61, 970, 10.1136/gutjnl-2011-300730 Whitson, 2015, Predictors of progression to high-grade dysplasia or adenocarcinoma in Barrett's esophagus, Gastroenterol Clin North Am, 44, 299, 10.1016/j.gtc.2015.02.005 Yousef, 2008, The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis, Am J Epidemiol, 168, 237, 10.1093/aje/kwn121 Rastogi, 2008, Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis, Gastrointest Endosc, 67, 394, 10.1016/j.gie.2007.07.019 Singh, 2014, Incidence of esophageal adenocarcinoma in Barrett's esophagus with low-grade dysplasia: a systematic review and meta-analysis, Gastrointest Endosc, 79, 897, 10.1016/j.gie.2014.01.009 Mathieu, 2014, Age and sex differences in the incidence of esophageal adenocarcinoma: results from the surveillance, epidemiology, and end results (SEER) registry (1973–2008), Dis Esophagus, 27, 757, 10.1111/dote.12147 Hvid-Jensen, 2011, Incidence of adenocarcinoma among patients with Barrett's esophagus, N Engl J Med, 365, 1375, 10.1056/NEJMoa1103042 de Jonge, 2010, Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study, Gut, 59, 1030, 10.1136/gut.2009.176701 Hardikar, 2013, The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett's esophagus, PLoS ONE, 8, e52192, 10.1371/journal.pone.0052192 Coleman, 2012, Tobacco smoking increases the risk of high-grade dysplasia and cancer among patients with Barrett's esophagus, Gastroenterology, 142, 233, 10.1053/j.gastro.2011.10.034 Odze, 2006, Diagnosis and grading of dysplasia in Barrett's oesophagus, J Clin Pathol, 59, 1029, 10.1136/jcp.2005.035337 13 Davison, 2018, Low-grade dysplasia diagnosis ratio and progression metrics identify variable Barrett's esophagus risk stratification proficiency in independent pathology practices, Gastrointest Endosc, 88, 807, 10.1016/j.gie.2018.06.017 Curvers, 2010, Low-grade dysplasia in Barrett's esophagus: overdiagnosed and underestimated, Am J Gastroenterol, 105, 1523, 10.1038/ajg.2010.171 Duits, 2015, Barrett's oesophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel, Gut, 64, 700, 10.1136/gutjnl-2014-307278 Moyes, 2016, Prevalent low-grade dysplasia: the strongest predictor of malignant progression in Barrett's columnar-lined oesophagus, Gut, 65, 360, 10.1136/gutjnl-2015-309978 Wani, 2011, Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus, Gastroenterology, 141, 1179, 10.1053/j.gastro.2011.06.055 Reid, 1988, Observer variation in the diagnosis of dysplasia in Barrett's esophagus, Hum Pathol, 19, 166, 10.1016/S0046-8177(88)80344-7 Montgomery, 2001, Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation, Hum Pathol, 32, 368, 10.1053/hupa.2001.23510 Ten Kate, 2018, Improved progression prediction in Barrett's esophagus with low-grade dysplasia using specific histologic criteria, Am J Surg Pathol, 42, 918, 10.1097/PAS.0000000000001066 Skacel, 2000, The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression, Am J Gastroenterol, 95, 3383, 10.1111/j.1572-0241.2000.03348.x Duits, 2017, Patients with Barrett's esophagus and confirmed persistent low-grade dysplasia are at increased risk for progression to neoplasia, Gastroenterology, 152, 993, 10.1053/j.gastro.2016.12.008 Kestens, 2016, Patients with Barrett's esophagus and persistent low-grade dysplasia have an increased risk for high-grade dysplasia and cancer, Clin Gastroenterol Hepatol, 14, 956, 10.1016/j.cgh.2015.12.027 Song, 2020, Persistent confirmed low-grade dysplasia in Barrett's esophagus is a risk factor for progression to high-grade dysplasia and adenocarcinoma in a US Veterans cohort, Dis Esophagus, 33, doz061 Falk, 2007, Extent of low-grade dysplasia in Barrett's esophagus: is it useful for risk stratification?, Am J Gastroenterol, 102, 494, 10.1111/j.1572-0241.2007.01067.x Singh, 2014, Incidence of esophageal adenocarcinoma in Barrett's esophagus with low-grade dysplasia: a systematic review and meta-analysis, Gastrointest Endosc, 79, 897, 10.1016/j.gie.2014.01.009 Moole, 2016, Progression from low-grade dysplasia to malignancy in patients with Barrett's esophagus diagnosed by two or more pathologists, World J Gastroenterol, 22, 8831, 10.3748/wjg.v22.i39.8831 Pouw, 2020, Radiofrequency ablation for low-grade dysplasia in Barrett's esophagus: long-term outcome of a randomized trial, Gastrointest Endosc, 10.1016/j.gie.2020.03.3756 Lee, 2014, Barrett esophagus in Asia: same disease with different pattern, Clin Endosc, 47, 15, 10.5946/ce.2014.47.1.15 Dong, 2013, Meta-analysis of Barrett's esophagus in China, World J. Gastroenterol, 19, 8770, 10.3748/wjg.v19.i46.8770